This is the second in a series of four papers updating the European Cystic Fibrosis Society (ECFS) standards for the care of people with CF. This paper focuses on establishing and maintaining health. The guidance is produced using an evidence-based framework and with wide stakeholder engagement, including people from the CF community. Authors provided a narrative description of their topic and statements, which were more directive. These statements were reviewed by a Delphi exercise, achieving good levels of agreement from a wide group for all statements. This guidance reinforces the importance of a multi-disciplinary CF team, but also describes developing models of care including virtual consultations. The framework for health is reinforced, including the need for a physically active lifestyle and the strict avoidance of all recreational inhalations, including e-cigarettes. Progress with cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy is reviewed, including emerging adverse events and advice for dose reduction and interruption. This paper contains guidance that is pertinent to all people with CF regardless of age and eligibility for and access to modulator therapy.

All Wales Adult Cystic Fibrosis Centre University Hospital Llandough Cardiff and Vale University Health Board Cardiff UK

Assistance Publique Hôpitaux de Paris Université Paris Cité Paris France

CF Center Cologne Children ́s Hospital Faculty of Medicine University Hospital Cologne Cologne Germany

CF Patient Head of Access Off label and Trials Computer Science Architecture Research and Innovation Cystic Fibrosis Foundation of Israel Israel

Copenhagen CF center Rigshospitalet Copenhagen Denmark

Cork Centre for Cystic Fibrosis Cork University Hospital Cork Ireland

Cystic Fibrosis Centre Pediatric Hospital Dziekanów Leśny Poland

Cystic Fibrosis Department Institute of Mother and Child Warsaw Poland

Cystic Fibrosis Europe Brussels Belgium and the Belgian CF Association Brussels Belgium

Cystic Fibrosis Reference Center Department of Pediatrics Ghent University Hospital Ghent Belgium

Department of Clinical Pharmacy and Pharmacology University Medical Center Groningen University of Groningen Groningen the Netherlands

Department of Internal Medicine and Paediatrics Faculty of Medicine and Health Sciences Ghent University Ghent Belgium

Department of Medical Microbiology 2nd Faculty of Medicine Motol University Hospital Charles University Prague Czech Republic

Department of Medicine Nursing and Health Sciences Monash University Melbourne Australia 3181 and Department of Respiratory Medicine Alfred Health Melbourne 3004 Australia

Department of Nutrition and Dietetics Royal Alexandra Children's Hospital Brighton UK

Department of Paediatric Respiratory and Sleep Medicine Royal Hospital for Children Glasgow UK

Department of Pathophysiology and Transplantation Università degli Studi di Milano Respiratory Unit and Adult Cystic Fibrosis Center Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Milano Italy

Department of Pediatrics Center for children and adolescents with diabetes Ghent University Hospital Ghent Belgium

Department of Psychiatry Massachusetts General Hospital Harvard Medical School Boston USA

Department of Respiratory Medicine The Children's Hospital at Westmead Sydney NSW Australia

Department of Thoracic Medicine and Faculty of Medicine The University of Queensland The Prince Charles Hospital Brisbane Australia

Department of Women's and Children's Health University of Liverpool Liverpool UK

Division of Respiratory Medicine Department of Medicine St Paul's Hospital and the University of British Columbia Vancouver British Columbia Canada

Divison of Pediatric Respiratroy Medicine BC Childrens Hospital Vancouver Canada

Epidemiology Biostatistics and Prevention Institute University of Zurich Zurich Switzerland

Epigenetics and Cell Fate Centre UMR7216 CNRS Université Paris Cité Paris France and Cystic Fibrosis Europe Brussels Belgium

Haga Teaching Hospital Pharmacy The Hague Netherlands

Hospital Necker Enfants Malades AP HP CF centre Université Paris Descartes Paris France

Hospital Universitari Vall d'Hebron Barcelona Spain

Imperial Biomedical Research Centre

Institute of Mother and Child in Warsaw Cystic Fibrosis Department and Dziekanow Lesny Hospital Cystic Fibrosis Center Dziekanow Lesny Poland

IRCCS Istituto Giannina Gaslini Via Gerolamo Gaslini 5 16147 Genova Italy

Laboratoire Educations et Promotion de la santé LEPS UR 3412 University of Sorbonne Paris Nord F 93430 Villetaneuse France

Medical Center University of Freiburg Pharmacy Hugstetter St 55 Freiburg D 79106 Germany

National Heart and Lung Institute Imperial College London

National Resource Centre for Cystic Fibrosis Oslo University Hospital Oslo Norway

Physical Activity Health and Rehabilitation Thematic Research Group School of Sport Health and Exercise Science Faculty of Science and Health University of Portsmouth UK and Wessex Cystic Fibrosis Unit University Hospitals Southampton NHS Foundation Trust UK

Population Policy and Practice Research and Teaching Department UCL Great Ormond Street Institute of Child Health London UK

Respiratory Medicine and Cystic Fibrosis National Reference Center Cochin Hospital Assistance Publique Hôpitaux de Paris and Université Paris Cité Institut Cochin Inserm U1016 Paris France

Royal Brompton Hospital Guy's and St Thomas' Trust London UK

School of Medicine Dentistry and Biomedical Sciences Queens University Belfast Belfast and NIHR Nottingham Biomedical Research Centre Nottingham UK

Seattle Children's Research Institute Seattle WA and Department of Pediatrics University of Washington Seattle Wa USA

Sydney Children's Hospital Australia

The Graub CF Center Pulmonary Institute Schneider Children's Medical Center Petah Tikva Israel

University Hospital Southampton NHS Foundation Trust Southampton United Kingdom

University of Leuven Leuven Belgium

West Midlands Adult CF Centre Heartlands Hospital Birmingham UK

West of Scotland Adult CF Centre Queen Elizabeth University Hospital Glasgow UK

Westmead Clinical School University of Sydney and CITRICA Dept Respiratory and Sleep Medicine Westmead Hospital Westmead Australia

000      

00000naa a2200000 a 4500

001      

bmc24007730

003      

CZ-PrNML

005      

20240423160219.0

007      

ta

008      

240412s2024 ne f 000 0|eng||

009      

AR

024    7_

$a 10.1016/j.jcf.2023.12.002 $2 doi

035    __

$a (PubMed)38129255

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a ne

100    1_

$a Southern, Kevin W $u Department of Women's and Children's Health, University of Liverpool, Liverpool, UK. Electronic address: kwsouth@liv.ac.uk

245    10

$a Standards for the care of people with cystic fibrosis; establishing and maintaining health / $c KW. Southern, C. Addy, SC. Bell, A. Bevan, U. Borawska, C. Brown, PR. Burgel, B. Button, C. Castellani, A. Chansard, MA. Chilvers, G. Davies, JC. Davies, K. De Boeck, D. Declercq, M. Doumit, P. Drevinek, I. Fajac, S. Gartner, AM. Georgiopoulos, S. Gursli, A. Gramegna, CM. Hansen, MJ. Hug, E. Lammertyn, EEC. Landau, R. Langley, N. Mayer-Hamblett, A. Middleton, PG. Middleton, M. Mielus, L. Morrison, A. Munck, B. Plant, M. Ploeger, DP. Bertrand, T. Pressler, BS. Quon, T. Radtke, ZL. Saynor, I. Shufer, AR. Smyth, C. Smith, S. van Koningsbruggen-Rietschel

520    9_

$a This is the second in a series of four papers updating the European Cystic Fibrosis Society (ECFS) standards for the care of people with CF. This paper focuses on establishing and maintaining health. The guidance is produced using an evidence-based framework and with wide stakeholder engagement, including people from the CF community. Authors provided a narrative description of their topic and statements, which were more directive. These statements were reviewed by a Delphi exercise, achieving good levels of agreement from a wide group for all statements. This guidance reinforces the importance of a multi-disciplinary CF team, but also describes developing models of care including virtual consultations. The framework for health is reinforced, including the need for a physically active lifestyle and the strict avoidance of all recreational inhalations, including e-cigarettes. Progress with cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy is reviewed, including emerging adverse events and advice for dose reduction and interruption. This paper contains guidance that is pertinent to all people with CF regardless of age and eligibility for and access to modulator therapy.

650    _2

$a lidé $7 D006801

650    12

$a cystická fibróza $x farmakoterapie $7 D003550

650    12

$a systémy dodávající nikotin elektronicky $7 D066300

650    _2

$a mutace $7 D009154

650    _2

$a protein CFTR $x genetika $7 D019005

650    12

$a látky ovlivňující dýchací systém $x terapeutické užití $7 D019141

655    _2

$a přehledy $7 D016454

655    _2

$a časopisecké články $7 D016428

700    1_

$a Addy, Charlotte $u All Wales Adult Cystic Fibrosis Centre, University Hospital Llandough, Cardiff and Vale University Health Board, Cardiff, UK

700    1_

$a Bell, Scott C $u Department of Thoracic Medicine and Faculty of Medicine, The University of Queensland, The Prince Charles Hospital, Brisbane, Australia

700    1_

$a Bevan, Amanda $u University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

700    1_

$a Borawska, Urzula $u Institute of Mother and Child in Warsaw, Cystic Fibrosis Department and Dziekanow Lesny Hospital, Cystic Fibrosis Center, Dziekanow Lesny, Poland

700    1_

$a Brown, Catherine $u West Midlands Adult CF Centre, Heartlands Hospital Birmingham, UK

700    1_

$a Burgel, Pierre-Régis $u Respiratory Medicine and Cystic Fibrosis National Reference Center, Cochin Hospital, Assistance Publique Hôpitaux de Paris (AP-HP) and Université Paris-Cité, Institut Cochin, Inserm U1016, Paris, France

700    1_

$a Button, Brenda $u Department of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia 3181, and Department of Respiratory Medicine, Alfred Health, Melbourne 3004, Australia

700    1_

$a Castellani, Carlo $u IRCCS Istituto Giannina Gaslini, Via Gerolamo Gaslini 5, 16147 Genova, Italy

700    1_

$a Chansard, Audrey $u Epigenetics and Cell Fate Centre, UMR7216 CNRS, Université Paris Cité, Paris, France, and Cystic Fibrosis Europe, Brussels, Belgium

700    1_

$a Chilvers, Mark A $u Divison of Pediatric Respiratroy Medicine, BC Childrens Hospital, Vancouver, Canada

700    1_

$a Davies, Gwyneth $u Population, Policy and Practice Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK

700    1_

$a Davies, Jane C $u National Heart & Lung Institute, Imperial College London; Imperial Biomedical Research Centre; Royal Brompton Hospital, Guy's & St Thomas' Trust, London, UK

700    1_

$a De Boeck, Kris $u University of Leuven, Leuven, Belgium

700    1_

$a Declercq, Dimitri $u Cystic Fibrosis Reference Center, Department of Pediatrics, Ghent University Hospital, Ghent, Belgium; Department of Pediatrics, Center for children and adolescents with diabetes, Ghent University Hospital, Ghent, Belgium; Department of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium

700    1_

$a Doumit, Michael $u Sydney Children's Hospital, Australia

700    1_

$a Drevinek, Pavel $u Department of Medical Microbiology, Second Faculty of Medicine, Motol University Hospital, Charles University, Prague, Czech Republic

700    1_

$a Fajac, Isabelle $u Assistance Publique - Hôpitaux de Paris, Université Paris Cité, Paris, France

700    1_

$a Gartner, Silvia $u Hospital Universitari Vall d'Hebron, Barcelona, Spain

700    1_

$a Georgiopoulos, Anna M $u Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, USA

700    1_

$a Gursli, Sandra $u National Resource Centre for Cystic Fibrosis, Oslo University Hospital, Oslo, Norway

700    1_

$a Gramegna, Andrea $u Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Italy

700    1_

$a Hansen, Carina Me $u Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen (UMCG), University of Groningen, Groningen, the Netherlands

700    1_

$a Hug, Martin J $u Medical Center - University of Freiburg, Pharmacy, Hugstetter St. 55, Freiburg, D-79106, Germany

700    1_

$a Lammertyn, Elise $u Cystic Fibrosis Europe, Brussels, Belgium and the Belgian CF Association, Brussels, Belgium

700    1_

$a Landau, Edwina Eddie C $u The Graub CF Center, Pulmonary Institute, Schneider Children's Medical Center, Petah Tikva, Israel

700    1_

$a Langley, Ross $u Department of Paediatric Respiratory & Sleep Medicine, Royal Hospital for Children, Glasgow, UK

700    1_

$a Mayer-Hamblett, Nicole $u Seattle Children's Research Institute, Seattle, WA and Department of Pediatrics, University of Washington, Seattle, Wa, USA

700    1_

$a Middleton, Anna $u Department of Respiratory Medicine, The Children's Hospital at Westmead, Sydney, NSW, Australia

700    1_

$a Middleton, Peter G $u Westmead Clinical School, University of Sydney and CITRICA, Dept Respiratory & Sleep Medicine, Westmead Hospital, Westmead, Australia

700    1_

$a Mielus, Monika $u Cystic Fibrosis Department, Institute of Mother and Child, Warsaw, Poland; Cystic Fibrosis Centre, Pediatric Hospital, Dziekanów Leśny, Poland

700    1_

$a Morrison, Lisa $u West of Scotland Adult CF Centre, Queen Elizabeth University Hospital, Glasgow, UK

700    1_

$a Munck, Anne $u Hospital Necker Enfants-Malades, AP-HP, CF centre, Université Paris Descartes, Paris, France

700    1_

$a Plant, Barry $u Cork Centre for Cystic Fibrosis (3CF), Cork University Hospital, Cork, Ireland

700    1_

$a Ploeger, Maarten $u Haga Teaching Hospital, Pharmacy, The Hague, Netherlands

700    1_

$a Bertrand, Dominique Pougheon $u Laboratoire Educations et Promotion de la santé, LEPS, UR 3412, University of Sorbonne Paris Nord, F-93430, Villetaneuse, France

700    1_

$a Pressler, Tacjana $u Copenhagen CF center, Rigshospitalet, Copenhagen, Denmark

700    1_

$a Quon, Bradley S $u Division of Respiratory Medicine, Department of Medicine. St. Paul's Hospital and the University of British Columbia. Vancouver, British Columbia, Canada

700    1_

$a Radtke, Thomas $u Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland

700    1_

$a Saynor, Zoe L $u Physical Activity, Health and Rehabilitation Thematic Research Group, School of Sport, Health and Exercise Science, Faculty of Science and Health, University of Portsmouth, UK and Wessex Cystic Fibrosis Unit, University Hospitals Southampton NHS Foundation Trust, UK

700    1_

$a Shufer, Ilan $u CF Patient, Head of Access, Off label and Trials, Computer Science Architecture, Research and Innovation, Cystic Fibrosis Foundation of Israel, Israel

700    1_

$a Smyth, Alan R $u School of Medicine, Dentistry and Biomedical Sciences, Queens University Belfast, Belfast and NIHR Nottingham Biomedical Research Centre, Nottingham, UK

700    1_

$a Smith, Chris $u Department of Nutrition and Dietetics, Royal Alexandra Children's Hospital, Brighton, UK

700    1_

$a van Koningsbruggen-Rietschel, Silke $u CF Center Cologne, Children ́s Hospital, Faculty of Medicine, University Hospital Cologne, Cologne, Germany

773    0_

$w MED00006892 $t Journal of cystic fibrosis $x 1873-5010 $g Roč. 23, č. 1 (2024), s. 12-28

856    41

$u https://pubmed.ncbi.nlm.nih.gov/38129255 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y - $z 0

990    __

$a 20240412 $b ABA008

991    __

$a 20240423160215 $b ABA008

999    __

$a ok $b bmc $g 2081610 $s 1217497

BAS    __

$a 3

BAS    __

$a PreBMC-MEDLINE

BMC    __

$a 2024 $b 23 $c 1 $d 12-28 $e 20231221 $i 1873-5010 $m Journal of cystic fibrosis $n J Cyst Fibros $x MED00006892

GRA    __

$a MR/T041285/1 $p Medical Research Council $2 United Kingdom

LZP    __

$a Pubmed-20240412